Arkolith/Insider Trading/GDTC/Form 4

Choo Chee Kong

Director, 10% OwnerCytoMed Therapeutics Ltd (GDTC) · full profile →Form 4 · filed Jun 15, 2026
Net Buying
Open-Market Buys
$129K
Open-Market Sells
$0
Net Open-Market Flow
$129K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 13, 2026Buy(P)112K$1.15$129K430K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-028589) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML